These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2555874)

  • 21. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils.
    Koike H; Imanishi N; Natsume Y; Morooka S
    Eur J Pharmacol; 1994 Nov; 269(3):299-309. PubMed ID: 7895770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion.
    Zimmerman GA; McIntyre TM; Mehra M; Prescott SM
    J Cell Biol; 1990 Feb; 110(2):529-40. PubMed ID: 2153685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor.
    Xu Z; Smith JS; Tian J; Byrnes AP
    Mol Ther; 2010 Mar; 18(3):609-16. PubMed ID: 19953082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic options directed against platelet activating factor, eicosanoids and bradykinin in sepsis.
    Fink MP
    J Antimicrob Chemother; 1998 Jan; 41 Suppl A():81-94. PubMed ID: 9511090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis.
    Pei Y; Barber LA; Murphy RC; Johnson CA; Kelley SW; Dy LC; Fertel RH; Nguyen TM; Williams DA; Travers JB
    J Immunol; 1998 Aug; 161(4):1954-61. PubMed ID: 9712066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
    Zingarelli B; Squadrito F; Bussolino F; Calapai G; Altavilla D; Ioculano M; Campo GM; Canale P; Caputi AP
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):123-34. PubMed ID: 8012759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
    Quinn JV; Slotman GJ
    Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paricalcitol effects on activities and metabolism of platelet activating factor and on inflammatory cytokines in hemodialysis patients.
    Verouti SN; Tsoupras AB; Alevizopoulou F; Demopoulos CA; Iatrou C
    Int J Artif Organs; 2013 Feb; 36(2):87-96. PubMed ID: 23335378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet activating factor interaction with tumor necrosis factor and myocardial depressant factor in splanchnic artery occlusion shock.
    Zingarelli B; Squadrito F; Ioculano M; Altavilla D; Bussolino F; Campo GM; Caputi AP
    Eur J Pharmacol; 1992 Nov; 222(1):13-9. PubMed ID: 1468489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there a case for PAF antagonists in the treatment of ischemic states?
    Braquet P; Paubert-Braquet M; Koltai M; Bourgain R; Bussolino F; Hosford D
    Trends Pharmacol Sci; 1989 Jan; 10(1):23-30. PubMed ID: 2688213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet activating factor-antagonist improves survival in experimental staphylococcal septicemia.
    Dirkes K; Harris BH; Connolly RJ; Schwaitzberg SD; Dinarello CA; Gelfand JA
    J Pediatr Surg; 1994 Aug; 29(8):1055-7; discussion 1057-8. PubMed ID: 7965505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a platelet activating factor antagonist (CV6209) on shock caused by temporary hepatic inflow occlusion.
    Fukuoka T; Nakajima Y; Matsumoto M; Segawa M; Kanehiro H; Hisanaga M; Wada T; Nakano H
    Life Sci; 1990; 47(6):565-70. PubMed ID: 2402181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in nitric oxide production in various forms of circulatory shock.
    Szabó C
    New Horiz; 1995 Feb; 3(1):2-32. PubMed ID: 7535648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet activating factor (PAF) antagonists on cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC).
    Wang JH; Sun GY
    Neurochem Res; 2000 May; 25(5):613-9. PubMed ID: 10905622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents.
    Braquet P; Hosford D
    J Ethnopharmacol; 1991 Apr; 32(1-3):135-9. PubMed ID: 1881152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Involvement of platelet activating factors in pathologic leukocyte-endothelium interactions in the liver after hemorrhagic shock].
    Marzi I; Bauer M; Reisdorf E; Walcher F
    Zentralbl Chir; 1994; 119(11):814-21. PubMed ID: 7846961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of adrenal steroids in the recovery from platelet activating factor challenge.
    Myers AK; Bader TJ
    Circ Shock; 1987; 23(2):143-50. PubMed ID: 3677334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autacoid binding to serum proteins. Interaction of platelet activating factor (PAF) with human serum alpha-1-acid glycoprotein (AAG).
    McNamara PJ; Brouwer KR; Gillespie MN
    Biochem Pharmacol; 1986 Feb; 35(4):621-4. PubMed ID: 3947392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure.
    Anderson BO; Bensard DD; Harken AH
    Surg Gynecol Obstet; 1991 May; 172(5):415-24. PubMed ID: 1851337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
    Ammit AJ; O'Neill C
    Lipids; 1991 Dec; 26(12):1189-92. PubMed ID: 1668116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.